63.06 Intestinal Alkaline Phosphatase Regulates Gut Barrier Function And Enhances Life Span In Drosophila

F. Adiliaghdam1, A. Tsurumi1,2,3, Y. Dhole1, J. Ramirez1, F. Kuehn1, A. Munoz1, S. Hamarneh1, L. Rahme1,2,3, R. Hodin1  1Massachusetts General Hospital,General Surgery,Boston, MA, USA 2Shriners Hospitals For Children,Boston, MA, USA 3Harvard School Of Medicine,Department Of Microbiology And Immunobiology,Brookline, MA, USA

Introduction: Intestinal barrier dysfunction is considered to be an underlying factor in the pathophysiology of aging.We have previously shown that the gut enzyme intestinal alkaline phosphatase(IAP) maintains a healthy gut mucosal barrier.We therefore hypothesized that IAP could play an important role in aging process.

Methods: The wild-type(WT) Oregon-R Drosophilia Melanogaster was used to study the changes of gut alkaline phosphatase(AP)activity with aging and the effect of IAP supplementation on lifespan.Strain y/w67C23 was used to develop double-cross mutants for the midgut-specific AP genes in D.melanogaster, CG5150 and CG10827, for lifespan analysis. Furthermore,Gut barrier function was assessed using feeding with a blue food dye. Junction protein gene expression (DECad: Drosophila E-Cadherin and dlg1:discs large 1genes) assayed by qPCR from dissected mid-guts of 35 day-old WT and AP double-cross mutants. Three independent trials were done for all experiments.

Results: We found that AP activity in WT D.melanogaster’s midgut decreased with aging (P< 0.0001). In WT flies, oral IAP supplementation caused major lifespan extension compared to vehicle controls (median survival: 53d vs. 47d, P<0.0001). Climbing assay showed that IAP-treated flies climbed better than the vehicle-treated controls (%24 increase at week3, P< 0.0001 and 10% increase at week5, P<0.01). We also found that the double-cross mutants lacking the two AP genes died earlier than the WT-flies (median survival:42d vs. 47d, P<0.0001) and also performed worse in the climbing assay (21% decrease P<0.001). WT-flies showed a significant age-dependent breakdown in the gut barrier and this impairment was much worse in the AP double-cross mutants.(Figure1) Furthermore, AP double-cross mutants had significantly reduced mRNA levels of Junction proteins in the midgut compared to WT flies: DECad (Mutants vs. WT, 0.491± 0.070 Vs.1.0± 0.14 Relative Expression ,P=0.001) and dlg1 (Mutants vs. WT, 0.607± 0.07 Vs.1.0± 0.26 Relative Expression, P<0.01)

Conclusion: Decreasing endogenous levels of IAP is an important factor in age-dependent loss of intestinal integrity.We believe that IAP supplementation could represent a novel therapy to delay aging process.